Xtant Medical acquires Coflex product line from Surgalign for $17M

Xtant Medical Holdings acquired the Coflex and Cofix product lines from Surgalign Holdings for $17 million, adding interlaminar stabilization devices for spinal stenosis.

“We are thrilled to acquire the Coflex and Cofix product lines, which will help accelerate our top-line growth and position Xtant to achieve critical mass.”globenewswire.com

• 1 source
• globenewswire.comXtant Medical Acquires Coflex® Product Line from SurgalignXtant Medical, Inc.Mar 1, 2023

Summarized from public sources; check the original articles before acting on it.